Drug Utilization Review Board
Meeting Agenda
Thursday, April 10, 2025
7:15 am to 8:30 am
Google Meet Joining Info
Video call link: meet.google.com/zue-rrqz-rpb
Or dial: (US) +1 904-900-0180 PIN: 172 873 306#
Persons who wish to address the DUR Board may contact Ngan Huynh at (nganhuynh@utah.gov) prior to the meeting, or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints.
1) Call to order- Sharon M. Weinstein, MD
a) Welcome and Introductions - Sharon M. Weinstein, MD
Housekeeping Staff Update - Sepideh Daeery, PharmD
b) Review and Approval of Minutes - Sharon M. Weinstein, MD
2) P&T Update - Ngan Huynh, PharmD
3) Review
a) Alyftrek & Other CTFF Modulators for Cystic Fibrosis
Review - Lauren Heath, PharmD
i) Public Comment
(1) Vertex: Alyftrek - Taha Khan, PharmD
(2) Alyftrek testimonial - Stacey Allen
(3) Alyftrek testimonial - Makinnon Baugh
(4) Alyftrek testimonial - Amy Baugh
(5) Eli Lilly: Zepbound - Beth Lubelcyzk, PharmD
i) Committee Discussion/Questions
ii) Committee Action
b) CF Modulators Prior Authorization - Ngan Huynh, PharmD
i) Committee Discussion/Questions
ii) Committee Action
c) Zepbound - (tirzepatide) -Ashley Park, PharmD
i) Committee Discussion/Questions
ii) Committee Action
4) Next Meeting
a) May 8, 2025 - Alhemo for Hemophilia and Zyntego Prior Authorization
5) Adjourned
Notice of Special Accommodations (ADA)
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Luis Moreno at 801-538-6155.
Notice of Electronic or Telephone Participation
Video call link: meet.google.com/zue-rrqz-rpb
Or dial: (US) +1 904-900-0180 PIN: 172 873 306#